使用CRISPRoff进行多重复合的表观遗传记忆编辑,使质母细胞瘤对化疗敏感
Katie Lin1,2, Christopher Zou1,2, Akane Hubbard1,2
1Department of Radiation Oncology, University of California San Francisco, San Francisco, CA 94143, USA.
Neuro-oncology
|February 25, 2025
概括
在表观遗传上,CRISPRoff使MGMT沉默,从而增强了质母细胞瘤的化疗. 这种可编程基因沉默提供了一种稳定,长期的战略,以改善这种侵袭性脑癌的治疗结果.
科学领域:
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 基因编辑 基因编辑
- 在瘤学瘤学.
背景情况:
- 质母细胞瘤 (GBM) 的预后不佳,需要新的治疗策略.
- 耐基化疗药物,如temozolomide (TMZ) 和lomustine (CCNU) 的耐药性是GBM治疗的一个主要挑战.
- O6-甲基氨酸-DNA甲基转移酶 (MGMT) 促进剂低甲基化是一个关键的抵抗机制.
研究的目的:
- 调查可编程表观遗传编辑器CRISPRoff的潜力,以提高TMZ和CCNU在GBM中的有效性.
- 评估由CRISPR引发的基因沉默的稳定性和遗传性.
- 探索CRISPRoff在GBM中克服化疗耐药性的能力.
主要方法:
- 通过电穿孔和脂质纳米颗粒 (LNP) 将CRISPR的mRNA和sgRNA暂时传递到GBM细胞系,初级培养和异种移植中.
- 评估基因抑制,特异性和稳定性,使用RT-qPCR,西斑,二硫酸盐测序和RNA测序.
- 通过细胞活力测定,显微镜和生物发光成像来评估化疗敏感性;全基因组的CRISPRi屏幕确定了CCNU敏感剂.
主要成果:
- 在超过8个月的时间里,CRISPRoff实现了稳定,完全抑制MGMT,从而在体外产生TMZ敏感性.
- 在体内研究表明,CRISPRoff介导的MGMT抑制对TMZ敏感的正统的GBM异种移植.
- 在患者衍生性GBM中,CRISPRoff的交付增强了化学敏感性,并且多重CRISPRoff针对CCNU敏感化所识别的漏洞.
结论:
- 暂时递送的CRISPRoff建立了稳定的,特定位置的表观遗传记忆,用于治疗性基因沉默.
- 这种方法为强化化疗和克服质母细胞瘤抵抗提供了一个有希望的策略.
- CRISPRoff使多重基因抑制能够用于组合治疗应用.
相关概念视频
CRISPR
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
Homologous Recombination
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
Conservative Site-specific Recombination and Phase Variation
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
CRISPR
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
CRISPR/Cas9 Genome Editing
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...


